denver developmental screening test ii pdf converter

We collected NSD1 gene analysis results, if there were any.

In our file screening, we screened the FISH results of all 16 patients, but not all patients had NSD1 gene analysis results. Sixteen patients suspected to have Sotos syndrome with clinical findings were examined retrospectively, ranging in ages between 3 and 23. The aim of this study is to evaluate the prenatal, natal, and postnatal clinical findings of patients with Sotos syndrome. Sotos syndrome is a non-progressive neurological disease with overgrowing, increased bone age, and developmental retardation. This should be considered for TTTS in cases of indication. Our study showed that fetoscopic laser ablation of selected fetal reduction surgery for treatment of special conditions of TTTS had no complications of operation, high neonatal survival result (90.48%), no short-term neurological complications. No short-term neurological complications have been reported with follow-up of the newborn to 6 months after birth. There were two stillbirths (9.52%) within seven days after the operation. The survival rate of newborns after the operation was 90.48%. The mean gestational age at birth was 34.70 ± 4.33 weeks, with a mean duration of 12.97 ± 6.87 weeks between intervention and delivery. No complications of operation, such as bleeding or infection, were recorded. The average operation duration was 39.52 minutes. The mean gestational age at operation was 20.30 weeks. Newborn neurologic complications were assessed at birth, three months, and six months after birth using Denver II test and magnetic resonance imaging (MRI). Prenatal care was carried out every 2 weeks post operation until birth. Complications and surgical outcomes were noted. To evaluate the surgery outcomes of fetoscopic laser ablation (FLA) for selective umbilical cord in treating twin-twin transfusion syndrome (TTTS) with special conditions and neonatal outcomes post-operation.Ī prospective study, 21 monochorionic diamniotic (MCDA) twins diagnosed with TTTS stage II-IV according to Quintero classification from 16 to 26 weeks of gestation, among that, 12 cases of TTTS stage II with selective intrauterine growth restriction (sIUGR), 6 cases of TTTS stage II with proximate cord insertions, 3 cases of TTTS stage IV underwent fetoscopic laser ablation for the selective fetal reduction at Hanoi Obstetrics and Gynecology Hospital from September 2019 to July 2021. In the interim, test users should employ screening tests which are more accurate such as the Minnesota Inventories or the Battelle Developmental Inventory Screening Test.

The findings suggest that the authors of the Denver-II need to engage in further development of the instrument including revising scoring criteria and item placement in relation to children's ages. Only items in the language domain were modestly helpful in discriminating children with and without difficulties. Since neither scoring method produced acceptable levels of accuracy, an effort was made to locate the sources of accuracy and inaccuracy within the test. The alternative scoring method, categorizing questionable/untestable scores as normal, caused sensitivity to drop to 56% although specificity rose to 80%. Thus the test had limited specificity (43%) and a high overreferral rate. However, more than half the children with normal development also received abnormal, questionable, or untestable Denver-II scores. The Denver-II identified correctly 83% and thus had high rates of sensitivity. Developmental problems including language impairments, learning disabilities, mild mental retardation, and/or functional developmental delay were found in 17% of the children. A second psychological examiner, blind to the outcome of the diagnostic battery, administered the Denver-II. To determine the presence of developmental problems, children were administered individual measures of intelligence, speech-language, achievement, and adaptive behavior. Because it was published without evidence of its accuracy, the present study was undertaken with 104 children between 3 and 72 months of age attending one of five day-care centers. One of the oldest and best known developmental screening tests was recently restandardized and revised as the Denver-II.

Denver developmental screening test ii pdf converter